TMDX INVESTIGATION: TransMedics Shares Remain Down
2 days ago · TMDX INVESTIGATION: TransMedics Shares Remain Down Following Report by Scorpion Capital; Investors Encouraged to Contact Block & Leviton to Potentially Recover …
TransMedics Responds to Inaccurate and Misleading Claims in …
Jan 13, 2025 · TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart …
TMDX INVESTIGATION: TransMedics Shares Remain Down
2 days ago · TMDX INVESTIGATION: TransMedics Shares Remain Down Following Report by Scorpion Capital; Investors Encouraged to Contact Block & Leviton to Potentially Recover …
TMDX Stock Down Despite Responding to Misleading Short-Seller …
6 days ago · TransMedics Group, Inc. (TMDX Quick Quote TMDX - Free Report) recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, …
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, …
Jan 14, 2025 · TransMedics’ stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An Egyptian,” leveling serious allegations against the company, …
TransMedics says claims made by Scorpion Capital ‘have no merit’
Jan 13, 2025 · TransMedics Group addressed what we believe are inaccurate and misleading claims made in a short-seller report issued by Scorpion Capital on January 10. In response, …
Berman Tabacco Announces Investigation of TransMedics
Jan 15, 2025 · Shares of TransMedics are down from a closing price of $72.55 per share on January 8, 2025 to a closing price of $62.54 on January 14, 2025, a decline of $10.01 or 13.8%.
TransMedics Shares Plunge Following Short Seller Allegations
Jan 10, 2025 · TransMedics Group (NASDAQ:TMDX) experienced a sharp decline in its stock price today, falling over 15% following the release of a critical report by Scorpion Capital. The …
Scorpion Capital shorts TransMedics, shares down - Yahoo Finance
Jan 10, 2025 · Investing.com -- Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of …
TransMedics Responds to Inaccurate and Misleading Claims in …
Jan 13, 2025 · The report fails to accurately represent TransMedics' business, technology, diverse culture and steadfast focus on delivering exceptional products and services to meet the needs …